拉尼提丁诱导的不良瘤事件:基于FAERS数据库的分析
ManTing Liu1, DongQiang Luo1, JiaZhen Jiang2
1Guangzhou University of Chinese Medicine, Clifford Hospital, Guangzhou, China.
Expert opinion on drug safety
|May 16, 2024
概括
拉尼蒂丁可能与各种瘤有关,特别是在长期和老年用户中. 需要进一步的研究来证实这种关联,并指导临床实践的ranitidine安全性.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 由于现实世界的证据有限,ranitidine和瘤发展之间的关联仍在争论中.
- 了解拉尼提丁诱导的潜在瘤风险对于临床决策至关重要.
研究的目的:
- 通过FDA不良事件报告系统 (FAERS) 数据库,调查ranitidine使用与所有瘤类型之间的联系.
- 为了为兰尼蒂丁的潜在瘤效应提供临床参考.
主要方法:
- 在FAERS数据库 (2004年第一季度 - 2023年第四季度) 中报告的拉尼蒂丁相关癌症病例的分析.
- 进行了人口特征分析和不成比例报告 (PRR) 分析.
主要成果:
- 总共有662,998例与拉尼蒂丁相关的癌症病例被确定.
- 在50-59岁和60-69岁的年龄组中,患病率最高.
- 拉尼蒂丁与98种不良事件有关,包括刑事和胃癌;不良事件在男性中更为频繁.
结论:
- 拉尼蒂丁可能与各种瘤不良事件有关,特别是在老年患者和长期使用时.
- 强化瘤查和避免长期使用ranitidine建议在风险人群.
- 没有确立因果关系;需要进行更大的前性研究.
相关概念视频
Pharmacovigilance
826
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
826
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
428
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
428
Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Peptic Ulcer Disease IV: Management
89
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
89
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422


